NIH-funded research NIH-funded research

Redbud NA1: a compact system to make reliable DNA/RNA extraction at scale

Official title: Redbud NA1 transfer to manufacturing

Funded at Redbud Labs, INC. · NIH-11262007 · Data updated 2026-11-12

A community-friendly project aims to move a small, automated nucleic acid extraction device into large-scale production to help disease surveillance work better, especially in field and resource-limited settings.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRedbud Labs, INC.
NIH-funded
Lab location1 site (Durham, UNITED STATES)
Project startJuly 22, 2026
Project endJune 30, 2029
Funding year2026
Award (this year)$956,224
NIH project number1SB1AI191998-01A1
Project IDNIH-11262007 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to patient enrollment; this is a device-focused manufacturing project.

Less likely to help

No direct patient participation or immediate clinical benefit in this phase.

What this research studies

This NIH SBIR project focuses on turning the Redbud NA1 sample prep platform into mass-manufactured products so researchers and public health teams can more reliably purify nucleic acids from many samples. The effort targets high-quality extraction that supports qPCR and sequencing for epidemic surveillance, while addressing quality, cost, and production capacity. By moving from prototype to manufacturing, the project seeks to deliver a robust, compact system suitable for diverse environments, including field and high-containment contexts. The work is designed to empower laboratories with a scalable tool to enable faster, more consistent data generation for monitoring disease threats.

Why it matters

Potential benefit: If successful, this could enable widespread, reliable nucleic acid extraction in places with limited infrastructure, improving turnaround times for disease surveillance.

How similar studies have gone: Previous prototypes exist; this project advances toward mass production, which has shown benefits in similar SBIR-developed devices.

Where this research is happening

  • Redbud Labs, INC.
    Durham, United States
    Active

Researchers

  • Principal investigator: Fisher, Jay Kenneth — Redbud Labs, INC.
  • Study coordinator: Fisher, Jay Kenneth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.